Abiomed Inc
ABMD
ABMD was delisted on the 21st of December, 2022.
297 hedge funds and large institutions have $4.67B invested in Abiomed Inc in 2016 Q4 according to their latest regulatory filings, with 42 funds opening new positions, 116 increasing their positions, 116 reducing their positions, and 45 closing their positions.
134% more call options, than puts
Call options by funds: $18.9M | Put options by funds: $8.08M
0% more funds holding in top 10
Funds holding in top 10: 9 → 9 (0)
0% more repeat investments, than reductions
Existing positions increased: 116 | Existing positions reduced: 116
7% less first-time investments, than exits
New positions opened: 42 | Existing positions closed: 45
3% less funds holding
Funds holding: 305 → 297 (-8)
8% less capital invested
Capital invested by funds: $5.1B → $4.67B (-$430M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$189M |
| 2 |
1832 Asset Management
Toronto,
Ontario, Canada
|
+$59.6M |
| 3 |
Millennium Management
New York
|
+$51M |
| 4 |
William Blair Investment Management
Chicago,
Illinois
|
+$31.6M |
| 5 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
+$31.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$77.2M |
| 2 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$70.6M |
| 3 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
-$44.9M |
| 4 |
D.E. Shaw & Co
New York
|
-$28.7M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$27.7M |
ABMD Hedge Fund Activity: Q4 2016 in Review
297 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Abiomed Inc (ABMD) for Q4 2016, worth a combined $4.67B — down 8.4% from $5.1B a quarter earlier.
Sellers outnumbered buyers: 45 funds closed out of ABMD and 42 opened new positions — a net loss of 3 holders — while 116 trimmed existing stakes and 116 added.
The largest buyer was Wellington Management Group, adding an estimated $189M. The largest seller was Lord, Abbett & Co, cutting an estimated $77.2M.
- 297 institutional investors held Abiomed Inc (ABMD) as of Q4 2016, down from 305 in Q3 2016.
- Funds reported $4.67B of Abiomed Inc stock for Q4 2016, down 8.4% quarter-over-quarter.
- 42 funds opened new Abiomed Inc positions in Q4 2016 and 45 closed out, a net change of -3 holders.
- The largest Abiomed Inc buyer in Q4 2016 was Wellington Management Group, an estimated $189M added.
- The largest Abiomed Inc seller in Q4 2016 was Lord, Abbett & Co, an estimated $77.2M sold.
Based on aggregated 13F filings for Q4 2016.